MEMBRANEBLUE (nda022278)- (0.15%)

Generic Name	TRYPAN BLUE	Innovator	DORC
Dosage	0.15%
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2019-Nov-12	NCE Excl Expiry	Expired
ODE Expiry	2011-Dec-16	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	MEMBRANEBLUE is indicated for use as an aid in ophthalmic posterior surgery; Facilitating removal of epiretinal tissue.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
0.15%	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of MEMBRANEBLUE